Find Eluxadoline manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Finished Drug Prices

NA

116 RELATED EXCIPIENT COMPANIES

201EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 864821-90-9, Viberzi, Truberzi, Jnj-27018966, Eluxadoline [usan], Jnj 27018966
Molecular Formula
C32H35N5O5
Molecular Weight
569.6  g/mol
InChI Key
QFNHIDANIVGXPE-FNZWTVRRSA-N
FDA UNII
45TPJ4MBQ1

Eluxadoline
Eluxadoline is a mixed mu-opioid receptor agonist, kappa-opioid receptor agonist, and a-delta opioid receptor antagonist indicated for use in diarrhea-predominant irritable bowel syndrome (IBS-D). The mu-, kappa-, and delta-opioid receptors mediate endogenous and exogenous opioid response in the central nervous system and peripherally in the gastrointestinal system. Agonism of peripheral mu-opioid receptors results in reduced colonic motility, while antagonism of central delta-opioid receptors results in improved analgesia, making eluxadoline usable for the symptoms of both pain and diarrhea characteristic of IBS-D. Marketed under the tradename Viberzi (FDA), eluxadoline is an antimotility agent that decreases bowel contractions, inhibits colonic transit, and reduces uid/ion secretion resulting in improved symptoms of abdominal pain and reductions in the Bristol Stool Scale.
Eluxadoline is a mu-Opioid Receptor Agonist. The mechanism of action of eluxadoline is as an Opioid mu-Receptor Agonist.
1 2D Structure

Eluxadoline

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[[[(2S)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid
2.1.2 InChI
InChI=1S/C32H35N5O5/c1-18-12-23(29(34)38)13-19(2)24(18)15-26(33)31(39)37(17-21-10-11-28(42-4)25(14-21)32(40)41)20(3)30-35-16-27(36-30)22-8-6-5-7-9-22/h5-14,16,20,26H,15,17,33H2,1-4H3,(H2,34,38)(H,35,36)(H,40,41)/t20-,26-/m0/s1
2.1.3 InChI Key
QFNHIDANIVGXPE-FNZWTVRRSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N
2.1.5 Isomeric SMILES
CC1=CC(=CC(=C1C[C@@H](C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)[C@@H](C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N
2.2 Other Identifiers
2.2.1 UNII
45TPJ4MBQ1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Viberzi

2.3.2 Depositor-Supplied Synonyms

1. 864821-90-9

2. Viberzi

3. Truberzi

4. Jnj-27018966

5. Eluxadoline [usan]

6. Jnj 27018966

7. 45tpj4mbq1

8. Chembl2159122

9. Chebi:85980

10. 864821-90-9 (free Base)

11. Eluxadoline (usan)

12. 5-(((s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-((s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid

13. 5-({(4-carbamoyl-2,6-dimethyl-l-phenylalanyl)[(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic Acid

14. Benzoic Acid, 5-((((2s)-2-amino-3-(4-(aminocarbonyl)-2,6-dimethylphenyl)-1-oxopropyl)((1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl)amino)methyl)-2-methoxy-

15. Eluxadoline [usan:inn]

16. Unii-45tpj4mbq1

17. Benzoic Acid, 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-

18. Viberzi (tn)

19. Eluxadoline [mi]

20. Eluxadoline [inn]

21. Eluxadoline [who-dd]

22. Gtpl7691

23. Dea No. 9725

24. Eluxadoline [nflis-drug]

25. Schembl12971682

26. Schembl17950908

27. Dtxsid70235589

28. Eluxadoline [orange Book]

29. Amy39829

30. Ex-a1169

31. Mfcd28386164

32. Zinc14210876

33. Akos030632800

34. Ccg-270093

35. Cs-3855

36. Db09272

37. Jnj27018966

38. Ncgc00485958-01

39. Ac-30329

40. As-35135

41. Hy-12247

42. Ft-0701295

43. J3.535.064k

44. A14085

45. D10403

46. Q20539232

47. 5-((((2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl)((1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl)amino(methyl)-2-methoxybenzoic Acid

48. 5-(((s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-((s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid

49. 5-((2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-(1-(5-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid

50. 5-[[[(2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1s)-1-(4-phenyl-3h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic Acid

51. 5-[[[(2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic Acid

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 569.6 g/mol
Molecular Formula C32H35N5O5
XLogP30.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count11
Exact Mass569.26381923 g/mol
Monoisotopic Mass569.26381923 g/mol
Topological Polar Surface Area165 Ų
Heavy Atom Count42
Formal Charge0
Complexity917
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the treatment of irritable bowel syndrome with diarrhea (IBS-D).


FDA Label


Truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS D).


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Gastrointestinal Agents

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
ELUXADOLINE
5.2.2 FDA UNII
45TPJ4MBQ1
5.2.3 Pharmacological Classes
mu-Opioid Receptor Agonist [EPC]; Opioid mu-Receptor Agonists [MoA]
5.3 ATC Code

A07


A - Alimentary tract and metabolism

A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents

A07D - Antipropulsives

A07DA - Antipropulsives

A07DA06 - Eluxadoline


5.4 Absorption, Distribution and Excretion

Absorption

The oral absorption of eluxadoline is poor - estimated to be 1.02%, this could be attributed to poor in vitro GI permeability, and its zwitterionic nature leading to a negatively charged molecule across the GI pH range.


Route of Elimination

82% excreted in feces, <1% excreted in urine.


5.5 Metabolism/Metabolites

The metabolism of eluxadoline is currently unclear, however evidence suggests limited glucoronidation forms an acyl glucuronide metabolite that is then excreted into urine.


5.6 Biological Half-Life

The mean plasma elimination half-life ranged from 3.7 hours to 6 hours.


5.7 Mechanism of Action

Eluxadoline is a mu-opioid receptor agonis, kappa opioid receptor agonist and a delta opioid receptor antagonist. Eluxadoline is used for diarrhea predominant IBS because it reduces intestinal contractility and normalizes stress-induced acceleration of upper GI transit. Antagonistic activity at the delta receptor minimizes the constipating effect usually seen by mu-opioid receptor agonists alone. Because of it's limited systemic bioavailability, there may be less side effects associated with the use of eluxadoline in comparison with other therapies used to treat diarrhea predominant IBS.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637951400,"product":"ELUXADOLINE(FCI 2853) STAGE - V","address":"","city":"","supplier":"PIRAMAL PHARMA SOLUTIONS","supplierCountry":"INDIA","foreign_port":"DUBLIN","customer":"ACTAVIS INC","customerCountry":"IRELAND","quantity":"153.85","actualQuantity":"153.85","unit":"KGS","unitRateFc":"970","totalValueFC":"147090.3","currency":"USD","unitRateINR":71199.220019499509,"date":"27-Nov-2021","totalValueINR":"10954000","totalValueInUsd":"147090.3","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"6317255","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688581800,"product":"ELUXADOLINE API (P)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PAR KAMANI JUNCTION, LBS MARG,","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA SOLUTIONS","supplierCountry":"INDIA","foreign_port":"CINCINNATI, OH","customer":"PATHEON","customerCountry":"UNITED STATES","quantity":"462.80","actualQuantity":"462.8","unit":"KGS","unitRateFc":"970","totalValueFC":"444326.7","currency":"USD","unitRateINR":78908.816637856537,"date":"06-Jul-2023","totalValueINR":"36519000.34","totalValueInUsd":"444326.7","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PAR KAMANI JUNCTION, LBS MARG,, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705689000,"product":"ELUXADOLINE(FCI 2853)PACKING(STAGE-II)(QTY:0.500 GMS)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA SOLUTIONS","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"SSRC THERMO FISHER SCIENTIFIC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"13790","totalValueFC":"6831.8","currency":"USD","unitRateINR":1135606.5,"date":"20-Jan-2024","totalValueINR":"567803.25","totalValueInUsd":"6831.8","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"6907651","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"ELUXADOLINE(FCI 2853) PACKING (INVOICE NO.7005152340 DT:26.08.2024)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA SOLUTIONS","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"PATHEON","customerCountry":"UNITED STATES","quantity":"332.69","actualQuantity":"332.69","unit":"KGS","unitRateFc":"1050","totalValueFC":"346401.5","currency":"USD","unitRateINR":87255,"date":"02-Sep-2024","totalValueINR":"29028865.95","totalValueInUsd":"346401.5","indian_port":"Hyderabad Air","hs_no":"29379090","bill_no":"3680399","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""}]
27-Nov-2021
02-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

INTERMEDIATES SUPPLIERS

read-more
read-more

01

BIO Partnering at JPM
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

CAS Number : 623950-02-7

End Use API : Eluxadoline

About The Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, c...

Aarti Industries Company Banner

02

BIO Partnering at JPM
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

CAS Number : 93267-04-0

End Use API : Eluxadoline

About The Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, c...

Aarti Industries Company Banner

03

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 3140-73-6

End Use API : Eluxadoline

About The Company : Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is established in 2009 and has an integrated focus from vario...

blank

04

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 78515-16-9

End Use API : Eluxadoline

About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...

blank

05

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 623950-02-7

End Use API : Eluxadoline

About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...

blank

06

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 864825-23-0

End Use API : Eluxadoline

About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Granulation

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 11484527

Drug Substance Claim :

Drug Product Claim :

Application Number : 206940

Patent Use Code : U-3475

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-14

Abbvie Company Banner

02

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 9789125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206940

Patent Use Code : U-1709

Delist Requested :

Patent Use Description : TREATMENT OF IRRITABLE...

Patent Expiration Date : 2028-07-07

Abbvie Company Banner

03

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 11311516

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-14

Abbvie Company Banner

04

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 9700542

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-14

Abbvie Company Banner

05

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 7786158

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-14

Abbvie Company Banner

06

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 9205076

Drug Substance Claim :

Drug Product Claim :

Application Number : 206940

Patent Use Code : U-1709

Delist Requested :

Patent Use Description : TREATMENT OF IRRITABLE...

Patent Expiration Date : 2025-03-14

Abbvie Company Banner

07

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 8772325

Drug Substance Claim :

Drug Product Claim :

Application Number : 206940

Patent Use Code : U-1709

Delist Requested :

Patent Use Description : TREATMENT OF IRRITABLE...

Patent Expiration Date : 2025-03-14

Abbvie Company Banner

08

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 9789125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206940

Patent Use Code : U-2152

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-07

Abbvie Company Banner

09

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 11229627

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-14

Abbvie Company Banner

10

ABBVIE

U.S.A
arrow
Pharmatech Expo 2025
Not Confirmed

ELUXADOLINE

US Patent Number : 8609709

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-14

Abbvie Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Eluxadoline Manufacturers

A Eluxadoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eluxadoline, including repackagers and relabelers. The FDA regulates Eluxadoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eluxadoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Eluxadoline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Eluxadoline Suppliers

A Eluxadoline supplier is an individual or a company that provides Eluxadoline active pharmaceutical ingredient (API) or Eluxadoline finished formulations upon request. The Eluxadoline suppliers may include Eluxadoline API manufacturers, exporters, distributors and traders.

click here to find a list of Eluxadoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Eluxadoline USDMF

A Eluxadoline DMF (Drug Master File) is a document detailing the whole manufacturing process of Eluxadoline active pharmaceutical ingredient (API) in detail. Different forms of Eluxadoline DMFs exist exist since differing nations have different regulations, such as Eluxadoline USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Eluxadoline DMF submitted to regulatory agencies in the US is known as a USDMF. Eluxadoline USDMF includes data on Eluxadoline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eluxadoline USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Eluxadoline suppliers with USDMF on PharmaCompass.

Eluxadoline WC

A Eluxadoline written confirmation (Eluxadoline WC) is an official document issued by a regulatory agency to a Eluxadoline manufacturer, verifying that the manufacturing facility of a Eluxadoline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Eluxadoline APIs or Eluxadoline finished pharmaceutical products to another nation, regulatory agencies frequently require a Eluxadoline WC (written confirmation) as part of the regulatory process.

click here to find a list of Eluxadoline suppliers with Written Confirmation (WC) on PharmaCompass.

Eluxadoline NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eluxadoline as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Eluxadoline API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Eluxadoline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Eluxadoline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eluxadoline NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Eluxadoline suppliers with NDC on PharmaCompass.

Eluxadoline GMP

Eluxadoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Eluxadoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eluxadoline GMP manufacturer or Eluxadoline GMP API supplier for your needs.

Eluxadoline CoA

A Eluxadoline CoA (Certificate of Analysis) is a formal document that attests to Eluxadoline's compliance with Eluxadoline specifications and serves as a tool for batch-level quality control.

Eluxadoline CoA mostly includes findings from lab analyses of a specific batch. For each Eluxadoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Eluxadoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Eluxadoline EP), Eluxadoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eluxadoline USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty